Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis

Phase

Condition

Eczema (Atopic Dermatitis)

Rash

Allergy

Treatment

N/A

Clinical Study ID

NCT01093469

IRB00009130

Ages 2-17
All Genders

Study Summary

The purpose of this study is to compare the efficacy and cost effectiveness of Aquaphor Healing Ointment, Atopiclair and EpiCeram as a monotherapy in mild to moderate AD.

The investigators hypothesize that no statistical difference will exist in the efficacy between an over-the-counter moisturizer, Aquaphor Healing Ointment, compared to prescription devices Atopiclair and EpiCeram in treating mild to moderate AD. Therefore, Aquaphor will be most cost-effective than Atopiclair or EpiCeram.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Male or female with mild to moderate atopic dermatitis, 2-17 years of age, that agreeto participate and provide written consent (and assent if applicable)
Have an investigator Global Assessment of mild to moderate atopic dermatitis (IGArating of 2-3 in the Investigator Global Assessment)
Percentage of overall body surface area of involvement (BSA) must be > 1% and mayinclude facial and intertriginous skin.

Exclusion

Exclusion Criteria:

Use within 4 weeks of baseline of systemic anti-inflammatory medication, which mayinfluence study outcome, such as systemic corticosteroids.
Application or use within 2 weeks of baseline of topical corticosteroid medications ortopical anti-inflammatory medication, which may influence study outcome.
Presence of a concurrent medical condition, which is determined by the investigator topotentially interfere with study outcomes or patient assessments.
Introduction of any other prescription medication, topical or systemic, for atopicdermatitis while participating int he study (oral antihistamines will be allowed, solong as they are neither initiated nor discontinued during the course of this study)
Amount of disease involvement that would require >60gm of cream in a 1 week period
Subjects with known allergy or sensitivity to Aquaphor Healing Ointment, Atopiclair orEpiCeram or components therein.

Study Design

September 01, 2009

February 28, 2010

Study Description

The primary objective is to compare the efficacy of Aquaphor Healing Ointment, Atopiclair Nonsteroidal Cream and EpiCeram Skin Barrier Emulsion in children with mild to moderate atopic dermatitis. The secondary objective is to compare the cost-effectiveness of these products. A significant difference exists in the cost of these products; therefore, if our hypothesis is proved correct - that Aquaphor will be just as efficacious as the more expensive counterparts Atopiclair and EpiCeram - this could have a significant impact on the overall cost of treating atopic dermatitis.

This is a single center, investigator blinded, randomized, prospective controlled study of subjects with mild to moderate atopic dermatitis. The study is intended to compare the efficacy of Aquaphor Healing Ointment, Atopiclair Nonsteroidal Cream and the EpiCeram Skin Barrier Emulsion used three times a day in treating mild to moderate atopic dermatitis. All subjects will receive active study medication and will return to study center for efficacy and safety assessments at Days 7 and 21. Approximately 50 subjects will be enrolled in order to obtain 39 completed subjects that will be randomized 1:1:1 (13 to receive Aquaphor, 13 to receive Atopiclair and 13 to receive EpiCeram) according to standard randomization tables. Efficacy will be measured through Investigator's Global Assessment, BSA involvement, Investigator Global Assessment of Improvement, Eczema Area and Severity Index and 100-pt Visual Analog Score for pruritis. Subjects will complete a Subject Global Assessment of Improvement and a drug diary to monitor for compliance. Cost benefit analysis will be calculated as cost in dollars for change in outcome according to EASI, BSA and VAS.

Connect with a study center

Wake Forest Baptist Medical Center
Winston-Salem, North Carolina 27157
United States
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.